Detalhe da pesquisa
1.
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
N Engl J Med
; 385(1): 46-58, 2021 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34192431
2.
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Haematologica
; 109(3): 906-914, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37646658
3.
First report of outcomes in patients with stage IIIb AL amyloidosis treated with Dara-VCD front-line therapy.
Br J Haematol
; 201(5): 913-916, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36896578
4.
Targeting the GCK pathway: a novel and selective therapeutic strategy against RAS-mutated multiple myeloma.
Blood
; 137(13): 1754-1764, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33036022
5.
Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis.
Blood
; 138(25): 2632-2641, 2021 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-34521113
6.
How do we manage t(11;14) plasma cell disorders with venetoclax?
Br J Haematol
; 199(1): 31-39, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35594184
7.
Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.
Int J Cancer
; 148(11): 2807-2814, 2021 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33529362
8.
Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.
J Natl Compr Canc Netw
; 17(1): 22-28, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30659126
9.
Reduced early mortality with Daratumumab-based frontline therapy in AL amyloidosis: A retrospective cohort study.
Am J Hematol
; 99(3): 477-479, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38100285
10.
Ixazomib as treatment for pyoderma gangrenosum associated with IgA smoldering multiple myeloma.
Ann Hematol
; 101(2): 441-442, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-33860355
11.
Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis.
Am J Hematol
; 97(7): E244-E246, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35385144
12.
Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.
Support Care Cancer
; 25(8): 2593-2601, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28365897
13.
Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein.
Int J Cancer
; 149(3): 743-744, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33742687
14.
Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation.
Am J Hematol
; 91(9): E341-7, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27238902
15.
Activated T cells armed with bispecific antibodies kill tumor targets.
Curr Opin Hematol
; 22(6): 476-83, 2015 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-26457960
16.
Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Biol Blood Marrow Transplant
; 21(1): 159-64, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25445637
17.
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Blood Cancer J
; 14(1): 35, 2024 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38443345
18.
A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation.
Am J Hematol
; 93(4): E96-E98, 2018 08.
Artigo
Inglês
| MEDLINE | ID: mdl-29318650
19.
Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.
Support Care Cancer
; 21(9): 2437-42, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23591714
20.
Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects.
Blood Adv
; 7(12): 2926-2937, 2023 06 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36827679